MAUDE MDR 9823525

MDR report key
9823525
Report number
2024168-2020-02308
Event key
0
Event type
3
Date of event
2020-02-19
Date received
2020-03-12
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
1
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MS. LINDSEY BELL
Address
26531 YNEZ RD. TEMECULA CA 92591 US
Phone
951-951-9519
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1STEERABLE GUIDE CATHETERVALVE REPAIRABBOTT VASCULARDRASGC0301SGC030191216U115R N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12020-03-120

Event Narratives#

N

Patient 1

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT. ADDITIONALLY, A REVIEW OF THE COMPLAINT HISTORY IDENTIFIED NO SIMILAR COMPLAINTS REPORTED FROM THIS LOT. ALL AVAILABLE INFORMATION WAS INVESTIGATED AND THE REPORTED DIFFICULT TO INSERT (ANATOMY) WAS A RESULT OF CHALLENGING ANATOMY AND OPERATIONAL CONTEXT. THE REPORTED DEFORMATION DUE TO COMPRESSIVE STRESS (SHAFT) WAS A CASCADING RESULT OF THE REPORTED DIFFICULT TO INSERT (ANATOMY). THE REPORTED CABLE BREAK WAS A RESULT OF OPERATIONAL CONTEXT AS IT WAS REPORTED THAT THE NEGATIVE KNOB WAS OVERROTATED ONCE THE SGC WAS REMOVED FROM THE ANATOMY. THE REPORTED AUDIBLE NOISE WAS DUE TO THE REPORTED CABLE BREAK. THERE IS NO INDICATION OF PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

D

Patient 1

THIS IS BEING FILED TO REPORT THE CABLE BREAK. IT WAS REPORTED THAT THIS WAS A MITRACLIP PROCEDURE TO TREAT DEGENERATIVE MITRAL REGURGITATION (MR) WITH A GRADE OF 4. RESISTANCE WAS MET INSERTING THE STEERABLE GUIDE CATHETER (SGC) INTO THE FEMORAL VEIN, RESULTING IN A KINK. THE SGC WAS REMOVED. THE NEGATIVE KNOB WAS TURNED PAST ? AND A POP WAS HEARD, THE CABLE WAS NOTED TO BE BROKEN. THE SGC WAS REPLACED WITH A NEW ONE AND TWO CLIPS WERE IMPLANTED, REDUCING MR TO 2. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO ADVERSE PATIENT EFFECTS.